precise-2-logo

PALOMA

Trial
Intervention Drug - ALENDRONATE -vs- PLACEBO
Number of sites 85
Countries involved 1
Sample size 8555
Type of statistical analyses
Risk of bias Overall: - details
Participant characteristics Age: >70
Condition: OSTEOPOROSIS
Baseline severity: T-SCORE >-2.5
Duration of trial 5 yrs
Primary outcome HIP FRACTURE
Show Score Ranges

Scores:

(shows median if more than one score was entered)

Elig. Recr. Setting Org. Int. Flex. Del. Flex. Adherence Follow-Up Prim. Out. Prim. An.
4 4 3 4 4 5 4 5 5